2022 ICD-10-CM Diagnosis Code D39.2

Neoplasm of uncertain behavior of placenta

    2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code Maternity Dx (12-55 years)
  • D39.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2022 edition of ICD-10-CM D39.2 became effective on October 1, 2021.
  • This is the American ICD-10-CM version of D39.2 - other international versions of ICD-10 D39.2 may differ.
ICD-10-CM Coding Rules
  • D39.2 is applicable to maternity patients aged 12 - 55 years inclusive.
Applicable To
  • Chorioadenoma destruens
  • Invasive hydatidiform mole
  • Malignant hydatidiform mole
Type 1 Excludes
Type 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as D39.2. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • hydatidiform mole NOS (
    ICD-10-CM Diagnosis Code O01.9

    Hydatidiform mole, unspecified

      2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code Maternity Dx (12-55 years)
    Applicable To
    • Trophoblastic disease NOS
    • Vesicular mole NOS
    O01.9
    )
The following code(s) above D39.2 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to D39.2:
  • C00-D49
    2022 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • D37-D48
    2022 ICD-10-CM Range D37-D48

    Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes

    Note
    • Categories D37-D44, and D48 classify by site neoplasms of uncertain behavior, i.e., histologic confirmation whether the neoplasm is malignant or benign cannot be made.
    Type 1 Excludes
    • neoplasms of unspecified behavior (D49.-)
    Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes
Clinical Information
  • A type of cancer that grows into the muscular wall of the uterus. It is formed after conception (fertilization of an egg by a sperm). It may spread to other parts of the body, such as the vagina, vulva, and lung.
  • A uterine tumor derived from persistent gestational trophoblasts, most likely after a molar pregnancy (hydatidiform mole). Invasive hyadatiform mole develops in about 15% of patients after evacuation of a complete mole and less frequently after other types of gestation. It may perforate the myometrium and erode uterine vessels causing hemorrhage.
  • This term is used when a complete mole or very rarely a partial mole invades the myometrium. Microscopically, villi of hydatidiform mole are present within the myometrium or the myometrial vessels. Patients have persistent or rising hcg levels.
ICD-10-CM D39.2 is grouped within Diagnostic Related Group(s) (MS-DRG v39.0):
  • 736 Uterine and adnexa procedures for ovarian or adnexal malignancy with mcc
  • 737 Uterine and adnexa procedures for ovarian or adnexal malignancy with cc
  • 738 Uterine and adnexa procedures for ovarian or adnexal malignancy without cc/mcc
  • 739 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy with mcc
  • 740 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy with cc
  • 741 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy without cc/mcc
  • 754 Malignancy, female reproductive system with mcc
  • 755 Malignancy, female reproductive system with cc
  • 756 Malignancy, female reproductive system without cc/mcc

Convert D39.2 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
Code annotations containing back-references to D39.2:
  • Type 1 Excludes: O01
    , O01
    , C58
    , C58
    , C58
    ICD-10-CM Diagnosis Code O01

    Hydatidiform mole

      2016 2017 2018 2019 2020 2021 2022 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • chorioadenoma (destruens) (D39.2)
    • malignant hydatidiform mole (D39.2)
    Use Additional
    • code from category O08 to identify any associated complication.
    ICD-10-CM Diagnosis Code O01

    Hydatidiform mole

      2016 2017 2018 2019 2020 2021 2022 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • chorioadenoma (destruens) (D39.2)
    • malignant hydatidiform mole (D39.2)
    Use Additional
    • code from category O08 to identify any associated complication.
    ICD-10-CM Diagnosis Code C58

    Malignant neoplasm of placenta

      2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code Maternity Dx (12-55 years) Female Dx
    Includes
    • choriocarcinoma NOS
    • chorionepithelioma NOS
    Type 1 Excludes
    • chorioadenoma (destruens) (D39.2)
    • hydatidiform mole NOS (O01.9)
    • invasive hydatidiform mole (D39.2)
    • male choriocarcinoma NOS (C62.9-)
    • malignant hydatidiform mole (D39.2)
    ICD-10-CM Diagnosis Code C58

    Malignant neoplasm of placenta

      2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code Maternity Dx (12-55 years) Female Dx
    Includes
    • choriocarcinoma NOS
    • chorionepithelioma NOS
    Type 1 Excludes
    • chorioadenoma (destruens) (D39.2)
    • hydatidiform mole NOS (O01.9)
    • invasive hydatidiform mole (D39.2)
    • male choriocarcinoma NOS (C62.9-)
    • malignant hydatidiform mole (D39.2)
    ICD-10-CM Diagnosis Code C58

    Malignant neoplasm of placenta

      2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code Maternity Dx (12-55 years) Female Dx
    Includes
    • choriocarcinoma NOS
    • chorionepithelioma NOS
    Type 1 Excludes
    • chorioadenoma (destruens) (D39.2)
    • hydatidiform mole NOS (O01.9)
    • invasive hydatidiform mole (D39.2)
    • male choriocarcinoma NOS (C62.9-)
    • malignant hydatidiform mole (D39.2)

Diagnosis Index entries containing back-references to D39.2:
  • Chorioadenoma D39.2 (destruens)
  • Hydatidiform mole (benign) (complicating pregnancy) (delivered) (undelivered) O01.9
    ICD-10-CM Diagnosis Code O01.9

    Hydatidiform mole, unspecified

      2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code Maternity Dx (12-55 years)
    Applicable To
    • Trophoblastic disease NOS
    • Vesicular mole NOS
    • invasive D39.2
    • malignant D39.2
  • Mola destruens D39.2
  • Mole (pigmented) - see also Nevus
    • hydatid, hydatidiform (benign) (complicating pregnancy) (delivered) (undelivered) O01.9
      ICD-10-CM Diagnosis Code O01.9

      Hydatidiform mole, unspecified

        2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code Maternity Dx (12-55 years)
      Applicable To
      • Trophoblastic disease NOS
      • Vesicular mole NOS
      • invasive D39.2
      • malignant D39.2
    • malignant
      • meaning
        • malignant hydatidiform mole D39.2
    • destructive D39.2
    • invasive D39.2 (hydatidiform)
  • Tumor - see also Neoplasm, unspecified behavior, by site
    • placental site trophoblastic D39.2
    • trophoblastic, placental site D39.2

ICD-10-CM Codes Adjacent To D39.2
D38.3 Neoplasm of uncertain behavior of mediastinum
D38.4 Neoplasm of uncertain behavior of thymus
D38.5 Neoplasm of uncertain behavior of other respiratory organs
D38.6 Neoplasm of uncertain behavior of respiratory organ, unspecified
D39 Neoplasm of uncertain behavior of female genital organs
D39.0 Neoplasm of uncertain behavior of uterus
D39.1 Neoplasm of uncertain behavior of ovary
D39.10 Neoplasm of uncertain behavior of unspecified ovary
D39.11 Neoplasm of uncertain behavior of right ovary
D39.12 Neoplasm of uncertain behavior of left ovary
D39.2 Neoplasm of uncertain behavior of placenta
D39.8 Neoplasm of uncertain behavior of other specified female genital organs
D39.9 Neoplasm of uncertain behavior of female genital organ, unspecified
D40 Neoplasm of uncertain behavior of male genital organs
D40.0 Neoplasm of uncertain behavior of prostate
D40.1 Neoplasm of uncertain behavior of testis
D40.10 Neoplasm of uncertain behavior of unspecified testis
D40.11 Neoplasm of uncertain behavior of right testis
D40.12 Neoplasm of uncertain behavior of left testis
D40.8 Neoplasm of uncertain behavior of other specified male genital organs
D40.9 Neoplasm of uncertain behavior of male genital organ, unspecified

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.